Lineweaver Wealth Advisors LLC Makes New $726,000 Investment in Danaher Co. (NYSE:DHR)

Lineweaver Wealth Advisors LLC acquired a new stake in shares of Danaher Co. (NYSE:DHR) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 3,156 shares of the conglomerate’s stock, valued at approximately $726,000.

Several other hedge funds and other institutional investors have also recently modified their holdings of the stock. Heck Capital Advisors LLC acquired a new position in Danaher during the 4th quarter valued at approximately $27,000. Decker Retirement Planning Inc. acquired a new position in shares of Danaher in the 4th quarter valued at $31,000. Golden State Wealth Management LLC purchased a new position in Danaher in the 4th quarter worth $31,000. Teachers Insurance & Annuity Association of America acquired a new stake in Danaher during the 3rd quarter worth about $39,000. Finally, MidAtlantic Capital Management Inc. purchased a new stake in Danaher during the 3rd quarter valued at about $40,000. 79.05% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Danaher

In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of the stock in a transaction dated Thursday, January 30th. The shares were sold at an average price of $224.13, for a total value of $1,277,541.00. Following the completion of the sale, the senior vice president now owns 20,230 shares in the company, valued at approximately $4,534,149.90. This represents a 21.98 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 11.10% of the company’s stock.

Danaher Price Performance

NYSE:DHR opened at $209.27 on Thursday. The stock has a 50 day moving average of $225.41 and a two-hundred day moving average of $245.78. Danaher Co. has a 12 month low of $196.80 and a 12 month high of $281.70. The firm has a market cap of $149.57 billion, a P/E ratio of 39.63, a price-to-earnings-growth ratio of 2.66 and a beta of 0.83. The company has a current ratio of 1.40, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31.

Danaher (NYSE:DHR) last issued its quarterly earnings results on Wednesday, January 29th. The conglomerate reported $2.14 EPS for the quarter, hitting the consensus estimate of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same quarter in the previous year, the business earned $2.09 earnings per share. On average, analysts expect that Danaher Co. will post 7.63 earnings per share for the current fiscal year.

Danaher Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be given a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.61%. This is a boost from Danaher’s previous quarterly dividend of $0.27. The ex-dividend date is Friday, March 28th. Danaher’s dividend payout ratio is 24.24%.

Analyst Ratings Changes

DHR has been the subject of a number of recent research reports. Barclays reduced their price target on shares of Danaher from $275.00 to $240.00 and set an “equal weight” rating for the company in a research report on Thursday, January 30th. Royal Bank of Canada reissued an “outperform” rating and set a $277.00 target price (down previously from $299.00) on shares of Danaher in a report on Thursday, January 30th. Citigroup decreased their price objective on Danaher from $285.00 to $265.00 and set a “buy” rating for the company in a report on Thursday, January 30th. Wolfe Research raised Danaher from a “peer perform” rating to an “outperform” rating and set a $285.00 target price on the stock in a report on Thursday, October 31st. Finally, Robert W. Baird decreased their price target on Danaher from $277.00 to $268.00 and set an “overweight” rating for the company in a report on Tuesday, January 28th. Seven analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. According to data from MarketBeat.com, Danaher has a consensus rating of “Moderate Buy” and an average price target of $278.00.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.